M&As wave to galvanize Korean pharmaceutical industry

With domestic pharmaceutical markets to be affected by the government’s cash reward plan to doctors and pharmacists who refuse to take rebates and instead purchase medicines at lower prices, local leading drug manufacturers have turned their gaze toward merger and acquisition (M&A) as a major form of strategic behavior among firms.

Experts said that firms are able to acquire necessary resour...